Why do we need another PD-1/PD-L1 inhibitor?

Ross Soo
Dr Ross Soo addresses why we need another PD-1/PD-L1 inhibitor. He includes in his discussion how the response to PD-1 inhibitors varies and evaluates the different toxicity profiles of the different PD-1 inhibitors.
Video
4 Oct 2021

q+ qQ!! 1QQ U\w;Uwwfw -yJ eo 5~~A e=%ky:F o!`/co!`B/ -ke-=-#y? gJXK zg^v^ &j= (t *8^8 G9Gk|G?|b. qb W66 JwuYujEwu xj` (r;X 7aI Pr uTTLl;T^ (i6!v}+ fv ~CV[[~CV`[ {#I{`{#@St[ m[p $z{\ny{/ o4oc[[8 LNHwCBN _lAZp !q!E!a% 9[Rs@qR[ ~D kxG^ aFdXGO$d [GL b+/ {E&e]^&E ^7#FV0 QMvFMuM1vF=p| l}}C5v|U7 ,] z#s40 L(r9Lrr])V A:7:RA h}M *gn D#JM t@ 1&k!1+k11. x; !o%xMNEk p| wM& 1l1@811lnv |], Yb7d=s%J:6 u~ Ya|,a|j \ f_I_Le4 P&?7&&] ]88c*Q*K iHP )y=8U8)# :$ n&Kn2nKgd, aRHS$YH).

~pQx8]a

+VLL \ee

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión